Classifying cephalosporins: from generation to cross-reactivity

Area of Science:

• Immunology
• Pharmacology
• Clinical Medicine

Background:

• Recent research focuses on cephalosporin allergy, including cross-reactivity with other beta-lactams and adverse reactions in penicillin-allergic individuals.
• Investigating new cephalosporin structures and their immunological recognition is also a key area of study.

Purpose of the Study:

• To review recent literature on cephalosporin allergy classifications.
• To examine the immunochemistry and cross-reactivity of cephalosporin allergy reactions.
• To synthesize current understanding of cephalosporin safety and immunological mechanisms.

Main Methods:

• Meta-analysis of numerous studies on cephalosporin allergy.
• Review of literature published within the last five years.
• Analysis of cross-reactivity data between cephalosporins, penicillins, and other beta-lactams.

Main Results:

• Cephalosporins are safer than previously believed, with low cross-reactivity in penicillin-allergic patients.
• Adverse reactions to cephalosporins are rare in patients with or without a history of penicillin allergy, particularly when used perioperatively.
• Limited progress has been made in identifying specific cephalosporin structures involved in allergic reactions for clinical application.

Conclusions:

• Cephalosporins can be safely administered to most patients, including those with a history of penicillin allergy.
• The risk of cross-reactivity between cephalosporins and penicillins is low.
• Further research is needed to elucidate the precise immunological mechanisms underlying cephalosporin allergy.